Determining stereoisomeric excess, concentration and absolute configuration
US-10900941-B2 · Jan 26, 2021 · US
US12486293B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12486293-B2 |
| Application number | US-201917265147-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 30, 2019 |
| Priority date | Jul 30, 2018 |
| Publication date | Dec 2, 2025 |
| Grant date | Dec 2, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to an analytical method that includes providing a sample potentially containing a chiral analyte that can exist in stereoisomeric forms, and providing a probe selected from the group consisting of coumarin-derived Michael acceptors, dinitrofluoroarenes and analogs thereof, arylsulfonyl chlorides and analogs thereof, arylchlorophosphines and analogs thereof, aryl halophosphites, and halodiazaphosphites. The sample is contacted with the probe under conditions to permit covalent binding of the probe to the analyte, if present in the sample; and, based on any binding that occurs, the absolute configuration of the analyte in the sample, and/or the concentration of the analyte in the sample, and/or the enantiomeric composition of the analyte in the sample is/are determined. The probe may be a coumarin-derived Michael acceptor, a di nitrofluoroarene or analog thereof, an arylsulfonyl chloride or analog thereof, an arylchlorophosphine or analog thereof, an aryl halophosphite, or a halodiazaphosphite.
Opening claim text (preview).
What is claimed is: 1 . An analytical method comprising: providing a sample containing a chiral analyte that can exist in stereoisomeric forms; providing an achiral probe selected from the group consisting of coumarin-derived Michael acceptors, dinitrofluoroarenes and analogs thereof, arylsulfonyl chlorides and analogs thereof, arylchlorophosphines and analogs thereof, aryl halophosphites, and halodiazaphosphites; contacting the sample with the probe under conditions to permit covalent binding of the probe to the analyte; and performing a first spectroscopic analysis using one of circular dichroism (CD), optical rotatory dispersion and polarimetry, and/or a second spectroscopic analysis using one of ultraviolet (UV) spectroscopy and fluorescence spectroscopy to obtain, based on any covalent binding that occurs during said contacting, one or more of an absolute configuration of the analyte in the sample, concentration of the analyte in the sample, and an enantiomeric composition of the analyte in the sample. 2 . The analytical method of claim 1 , wherein the probe is a coumarin-derived Michael acceptor of Formula I: wherein: Y is hydrogen or an electron withdrawing group selected from the group consisting of —CF 3 , —C(O)R a , —SO 2 R a , —CN, and —NO 2 ; wherein each R a is independently selected from the group consisting of —H, -alkyl, —O-alkyl, —N-alkyl, -alkenyl, -alkynyl, -aryl, —O-aryl, —N-aryl, -heteroaryl, —O-heteroaryl, —N-heteroaryl, -cycloalkyl, —O-cycloalkyl, —N-cycloalkyl, -heterocycloalkyl, —O-heterocycloalkyl, and —N-heterocycloalkyl; and X is a leaving group selected from a halogen, —OR b , —OC(O)R b , —OS(O) 2 R b , —S(O) 2 —O—R b , —N 2 + , —N + (R b ) 3 , —S + (R b ) 2 , and —P + (R b ) 3 ; wherein each R b is independently selected from the group consisting of -alkyl, —O-alkyl, —N-alkyl, -alkenyl, -alkynyl, perfluoroalkyl, -perfluoroalkenyl, -perfluoroalkynyl, -aryl, perfluoroaryl, —O-aryl, —N-aryl, —O-perfluoroaryl, —N-perfluoroaryl, -heteroaryl, —O-heteroaryl, —N-heteroaryl, -cycloalkyl, —O-cycloalkyl, —N-cycloalkyl, -heterocycloalkyl, —O-heterocycloalkyl, and —N-heterocycloalkyl. 3 . The analytical method of claim 2 , wherein the probe is a coumarin-derived Michael acceptor selected from the group consisting of: 4 . The analytical method of claim 2 , wherein the probe is a coumarin-derived Michael acceptor and the analyte is an amino acid or an amino alcohol, or comprises one or more functional groups selected from the group consisting of amines, carboxylic acids, hydroxy acids, and thiols. 5 . The analytical method of claim 1 , wherein the probe is a dinitrofluoroarene or analog thereof of Formula II: wherein: each Y is independently selected from the group consisting of —NO 2 , —CN, —C(O)R a , and —SO 2 R a , wherein each R a is independently selected from the group consisting of —H, -alkyl, —O-alkyl, —N-alkyl, -alkenyl, -alkynyl, -perfluoroalkyl, -aryl, -perfluoroaryl, —O-aryl, —N-aryl, -heteroaryl, —O-heteroaryl, —N-heteroaryl, -cycloalkyl, —O-cycloalkyl, —N-cycloalkyl, -heterocycloalkyl, —O-heterocycloalkyl, and —N-heterocycloalkyl; X is a leaving group selected from halogen, —OR b , —OC(O)R b , —OS(O) 2 R b , —S(O) 2 —O—R b , —N 2 + , —N + (R b ) 3 , —S + (R b ) 2 , and —P + (R b ) 3 ; wherein each R b is independently selected from the group consisting of -alkyl, —O-alkyl, —N-alkyl, -alkenyl, -alkynyl, -perfluoroalkyl, -perfluoroalkenyl, -perfluoroalkynyl, -aryl, -perfluoroaryl, —O-aryl, —N-aryl, -heteroaryl, —O-heteroaryl, —N-heteroaryl, -cycloalkyl, —O-cycloalkyl, —N-cycloalkyl, -heterocycloalkyl, —O-heterocycloalkyl, and —N-heterocycloalkyl; and R 1 is selected from the group consisting of —NH 2 , —NHC(O)CH 2 Ar, —NHC(O)Ar, -hydrogen, -alkyl, —O-alkyl, —N-alkyl, -alkenyl, -alkynyl, -aryl, —O-aryl, —N-aryl, -heteroaryl, —O-heteroaryl, —N-heteroaryl, -cycloalkyl, —O-cycloalkyl, —N-cycloalkyl, -heterocycloalkyl, —O-heterocycloalkyl, —N-heterocycloalkyl, —CN, —C(O)R c , —CO 2 R c , —SO 2 R c , —C(O)NHR c , —S-alkyl, —S-aryl, and —S-heteroaryl; wherein: each R c is independently -Ar, -alkyl, or —CH 2 Ar; and each Ar is independently an aryl, heteroaryl, cycloalkyl, heterocycloalkyl, perfluoroalkyl, or perfluoroaryl. 6 . The analytical method of claim 5 , wherein the probe is a dinitroflourarene selected from: 7 . The analytical method of claim 1 , wherein the probe is an arylsulfonyl chloride or analog thereof of Formula III: wherein: X is selected from the group consisting of -halogen, —O-aryl, —O-heteroaryl, —O-cycloalkyl, —O-heterocycloalkyl, —O-alkyl, —O-perfluoroalkyl, —O-perfluoroaryl, —N-aryl, —N-heteroaryl, —N-cycloalkyl, —N-heterocycloalkyl, —N-alkyl, —N-perfluoroalkyl, —N-perfluoroaryl, —N(Ar)SO 2 Ar, —NHSO 2 Ar, and —NHAr; and R 2 is an aryl or heteroaryl, wherein the aryl or heteroaryl is optionally substituted with one or more groups selected from-alkyl, —O-alkyl, —N-alkyl, -alkenyl, -alkynyl, —O-aryl, —O-heteroaryl, —N-aryl, —N-heteroaryl, -aryl, —C(O)R c , —CO 2 R c , —O—C(O)R c , —NHC(O)R c , —NR c C(O)R c , —NO 2 , —CN, -halogen, and —SO 2 R c , wherein each R c is independently Ar, alkyl, or CH 2 Ar; wherein each Ar is independently an aryl or heteroaryl. 8 . The analytical method of claim 7 , wherein the probe is the arylsulfonyl chloride: 9 . The analytical method of claim 1 , wherein the probe is an arylchlorophosphine or analog thereof of Formula IV: wherein: X is selected from the group consisting of -halogen, —O-aryl, —O-heteroaryl, —O-cycloalkyl, —O-heterocycloalkyl, —O-alkyl, —O-perfluoroalkyl, and —O-perfluoroaryl; and each R 2 is independently an aryl or heteroaryl, wherein the aryl or heteroaryl is optionally substituted with one or more groups selected from-alkyl, —O-alkyl, —N-alkyl, -alkenyl, -alkynyl, —O-aryl, —O-heteroaryl, —N-aryl, —N-heteroaryl, -aryl, —C(O)R c , —CO 2 R c , —O—C(O)R c , —NHC(O)R c , —NR c C(O)R c , —NO 2 , —CN, -halogen, and —SO 2 R c , wherein each R c is independently Ar, alkyl, or CH 2 Ar and Ar is an aryl or heteroaryl. 10 . The analytical method of claim 9 , wherein the probe is the arylchlorophosphine: 11 . The analytical method of claim 1 , wherein the probe is an aryl halophosphite of Formula V: wherein: X is a halogen; and (i) R 3 and R 4 are each independently an aryl or heteroaryl, wherein the aryl or heteroaryl is optionally substituted with one or more groups selected from-alkyl, —O-alkyl, —N-alkyl, -alkenyl, -alkynyl, —O-aryl, —O-perfluoroaryl, —O-heteroaryl, —N-aryl, —N-heteroaryl, -aryl, —C(O)R c , —CO 2 R c , —O—C(O)R c , —NHC(O)R c , —NR c C(O)R c , —NO 2 , —CN, -halogen, and —SO 2 R c , wherein each R
using ultraviolet light (G01N21/39 takes precedence) · CPC title
condensed with carbocyclic or heterocyclic rings or ring systems · CPC title
Halophosphines · CPC title
substituted otherwise than in position 3 or 7 · CPC title
Cyclic amide derivatives of acids of phosphorus, in which two nitrogen atoms belong to the ring · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.